Multiple Myeloma Education | Blood Cancer Info

Multiple myeloma is a rare blood cancer that arises from the plasma cells, a type of white blood cell which is made in the bone marrow. These plasma cells become abnormal, multiply and release a type of antibody known as paraprotein, which causes symptoms of the disease, including bone pain, frequent or recurring infections and fatigue, a symptom of anemia. These malignant plasma cells have the potential to cause a number of serious health problems affecting the bones, immune system, kidneys and red blood cell count. ¹

Multiple myeloma is the second most common blood cancer. ² As of 2022, nearly 188,000 people around the world currently live with multiple myeloma. ³

Although advances in treatment have improved outcomes, multiple myeloma remains an incurable, life-threatening disease characterized by multiple relapses, with substantial burdens on patients and caregivers. ⁴

By listing these resources, Takeda Oncology is not endorsing any particular service or group, and we are not responsible for the content of these sites or services. They are provided here for informational purposes and are not meant to replace your healthcare provider's medical advice.